AG
PARN

Advisor Group’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Advisor Group’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,507
Closed -$1K – 4995
2016
Q4 		$1K Hold
1,507
– – ﹤0.01% 4480
2016
Q3 		$2K Hold
1,507
– – ﹤0.01% 4263
2016
Q2 		$2K Buy
+1,507
New +$2.77K ﹤0.01% 4174

Other funds holding PARN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Advisor Group's PARN Position: Q1 2017 in Review

Advisor Group sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2017, closing a stake of 1,507 shares — an estimated $1K sold.

Advisor Group first reported a position in PARN in Q2 2016 and held it in 3 quarters. The position peaked at $2K in Q3 2016. 2 funds tracked by Wall St. Rank hold PARN as of Q1 2017.

  • Advisor Group reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2017 after selling out during the quarter.
  • Advisor Group sold 1,507 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2017, an estimated $1K.
  • Advisor Group first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q2 2016 and held it in 3 quarters.
  • Advisor Group's Parnell Pharmaceuticals Holdings Ltd position peaked at $2K in Q3 2016.
  • 2 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2017.

Based on Advisor Group's 13F filing for Q1 2017, filed 15 May 2017.